Associate Professor Borislava Mihaylova
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Cost-effectiveness of statin therapy in categories of patients in the UK
Event: ESC Congress 2022
Topic: Health Policy
Session: Costs and cost-effectiveness
Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy
Event: ESC Congress 2018
Topic: Scores
Session: Controversies in cardiovascular risk assessment and prevention
ESC 365 is supported by
